Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

uniQure Appoints SVP, Investor Relations And Communications

Executive Summary

Gene therapy specialist uniQure N.V. has appointed Maria E. Cantor senior vice president, investor relations and communications. Cantor has over 20 years of communications experience in the biotech and healthcare industry, most recently at ARIAD Pharmaceuticals, where she was senior vice president, corporate affairs. Prior to this, she was senior director, corporate communications at Genzyme Inc., having previously held senior positions at the St. Elizabeth Medical Center in Boston, US, and at Optima Healthcare Inc.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst